$30,000 Millionaire said:
Long tomorrow 395C at 1.5. Stop 1.1
I don't like the action. Going to scratch the trade.
$30,000 Millionaire said:
Long tomorrow 395C at 1.5. Stop 1.1
If this hits for the third time I am joining. I bought puts at 395.11. If the 392 gets rejected a third time, I am selling my puts and reversing.Charismatic Megafauna said:
Let's buy those dudes back at the next 392 touch
South Platte said:Not a short term treasury leveraged ETF, but I'm up 22% on TMF, a 20 year treasury bull ETF. I only got in after watching TTT churn up smoothly all of 2022 and then start to pull back.BaylorSpineGuy said:Bonfire1996 said:
2 year treasury is now 15 basis points below where rates will be in 8 days. This is the first time this has happened during the Fed's current tightening cycle. For the past year, the 2 year treasury has listened to Powell and other members, and accelerated past where the next move was anticipated to go.
Translated: Market is telling the FED, "you don't have the balls to keep rates at next week's level for very long."
We are in a dangerous place for fiscal policy at the moment.
So if the 2 yr yield is gonna drop (and looks to have already peaked), are there any leveraged ETF's to trade to gain exposure to the short term bond?
It looks like it's in a big H&S pattern now with the neckline around 4.25. A break below there and it could drop pretty aggressively with significant move in bond price.
Excellent! I'm clapping for you man!Triple_Bagger said:
We're up 15% today! Don't rain on our parade Johnson!
Txducker said:
You can tell when I have a day off because I can't quit posting.
DFW area. I grew up a duck hunting every weekend with my Dad (mostly cedar creek lake) in the 80's. Moved to Mt Pleasant Tx after A&M and hunted that area a lot. Now back in DFW, it's been years since I have gone. I hate living in the city!!!!Charismatic Megafauna said:Txducker said:
You can tell when I have a day off because I can't quit posting.
I dig it man, enjoying the stream of consciousness!
Username doesn't check out, however. You know it's duck season, right? (North zone at least)
I liked $CAT short yesterday, then added to my puts on the spike up to $229. I expect in the next couple days it will break the $225 level and then has room to around $210 pic.twitter.com/Bs3zsh4zGy
— Kira Turner (@KirasEpicTrades) December 7, 2022
Don't forget the gif.jj9000 said:No.Charismatic Megafauna said:Txducker said:
You can tell when I have a day off because I can't quit posting.
I dig it man, enjoying the stream of consciousness!
Username doesn't check out, however. You know it's duck season, right? (North zone at least)
It's Rabbit season.
BOIL is a tough one to manage. I went ahead and sold 12/16 C30s on all my shares today locking in an 11% profit if we close over $30 on 12/16.Brian Earl Spilner said:
Trying to decide if I want to take profits on BOIL quite yet.
Triple_Bagger said:
SAVA
AUSTIN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc.(SAVA) , a clinical-stage biotechnology company, today announced the completion of drug administration in an open-label study of simufilam for Alzheimer's disease. This study was designed to evaluate long-term drug safety and to measure cognitive changes (ADAS-cog) over 12 months in approximately 200 patients with mild-to-moderate Alzheimer's disease treated with open-label simufilam 100 mg twice daily. Simufilam is Cassava Sciences' oral drug candidate for Alzheimer's disease dementia.
To ensure the highest integrity of data analysis, outside biostatisticians with specific expertise in Alzheimer's disease will conduct an independent statistical analysis on the clinical dataset. Cassava Sciences(SAVA) may announce study results approximately year-end 2022, pending completion of a study report by outside biostatisticians.
"We are thrilled with the progress made to date in the clinical development of simufilam, our oral drug candidate for people with Alzheimer's disease," said Remi Barbier, President & CEO. "We applaud recent clinical advances with anti-amyloid antibody drugs for Alzheimer's, but these may not be enough. I think innovations are needed around new targets, new molecules, drug safety and dosing. I believe Cassava Sciences(SAVA) may be at the forefront of this effort to innovate."
ugh another terrible day, down 7.8%... any tips on when to let something die, versus when to keep buying in? right now my average cost is 34.00 and this is trading at 17.75... its a great opportunity to get more shares at half off, but if this thing is headed for a cliff...Foamcows said:
Anyone else here monitoring $ZIM? been invested in it for quite some time, and been cost averaging it down as it drops, but its starting to get extremely painful and I am wondering if I am missing some red flags?
It really depends if you're trading or investing and what you think the future value of the company will be.Foamcows said:ugh another terrible day, down 7.8%... any tips on when to let something die, versus when to keep buying in? right now my average cost is 34.00 and this is trading at 17.75... its a great opportunity to get more shares at half off, but if this thing is headed for a cliff...Foamcows said:
Anyone else here monitoring $ZIM? been invested in it for quite some time, and been cost averaging it down as it drops, but its starting to get extremely painful and I am wondering if I am missing some red flags?
good way to think about it... based on the criteria, i would say I'm on the investor side, but starting to worry if i missed some red flags in the financials... they are sitting on nearly 5 billion in cash and cratering for reasons i cant seem to understand.Triple_Bagger said:It really depends if you're trading or investing and what you think the future value of the company will be.Foamcows said:ugh another terrible day, down 7.8%... any tips on when to let something die, versus when to keep buying in? right now my average cost is 34.00 and this is trading at 17.75... its a great opportunity to get more shares at half off, but if this thing is headed for a cliff...Foamcows said:
Anyone else here monitoring $ZIM? been invested in it for quite some time, and been cost averaging it down as it drops, but its starting to get extremely painful and I am wondering if I am missing some red flags?
If you're an investor, then you should be happy to buy at a 50% discount from where you started buying.
If you're a trader, then it's more complicated. You should have a stop price in mind when you buy. Down 50% should be well below your stop price. The decision to average down depends if there are better opportunities for your money or not.
Charismatic Megafauna said:
I just went ahead and grabbed a 394c for tomorrow